View in EDS

Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia.

Saved in:
Bibliographic Details
Title: Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia.
Authors: Vicente-Garcés C; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain., Maynou J; Hospital Sant Joan de Déu Barcelona, Genetics Medicine Section, Esplugues de Llobregat, Spain.; Institut de Recerca Hospital Sant Joan de Déu, Neurogenetics and Molecular Medicine, Esplugues de Llobregat, Spain., Fernández G; Hospital Sant Joan de Déu Barcelona, Genetics Medicine Section, Esplugues de Llobregat, Spain.; Institut de Recerca Hospital Sant Joan de Déu, Neurogenetics and Molecular Medicine, Esplugues de Llobregat, Spain., Esperanza-Cebollada E; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain., Torrebadell M; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain.; Hospital Sant Joan de Déu Barcelona, Hematology Laboratory, Esplugues de Llobregat, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red De Enfermedades Raras (CIBERER), Madrid, Spain., Català A; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red De Enfermedades Raras (CIBERER), Madrid, Spain.; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan De Déu Barcelona, Leukemia and Lymphoma Unit, Barcelona, Spain., Rives S; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red De Enfermedades Raras (CIBERER), Madrid, Spain.; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan De Déu Barcelona, Leukemia and Lymphoma Unit, Barcelona, Spain., Camós M; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain.; Hospital Sant Joan de Déu Barcelona, Hematology Laboratory, Esplugues de Llobregat, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red De Enfermedades Raras (CIBERER), Madrid, Spain., Vega-García N; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Esplugues de Llobregat, Spain.; Hospital Sant Joan de Déu Barcelona, Hematology Laboratory, Esplugues de Llobregat, Spain.
Source: Frontiers in molecular biosciences [Front Mol Biosci] 2023 Jun 09; Vol. 10, pp. 1141310. Date of Electronic Publication: 2023 Jun 09 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2296-889X
DOI:10.3389/fmolb.2023.1141310